BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04700072-completion@plaintrial.com
DTSTAMP:20261029T013855Z
DTSTART;VALUE=DATE:20251017
SUMMARY:Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination W
 ith Investigational Agents or Pembrolizumab Alone in Participants With Mel
 anoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) — estimated completion
  date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04700072
URL:https://plaintrial.com/trial/NCT04700072
END:VEVENT
END:VCALENDAR